Dimebon Slows Progression of Proteinopathy in γ-Synuclein Transgenic Mice

Dimebon (Latrepirdine) Enhances Mitochondrial Function and Protects Neuronal Cells from Death

(2017) Shouting Zhang et al.   JOURNAL OF ALZHEIMERS DISEASE

The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys

(2011) Scott J Webster et al.   BRITISH JOURNAL OF PHARMACOLOGY

Preclinical study of dimebon on β-amyloid-mediated neuropathology in Alzheimer's disease

(2011) Jun Wang et al.   Molecular Neurodegeneration

Dimebon Does Not Ameliorate Pathological Changes Caused by Expression of Truncated (1–120) Human Alpha-Synuclein in Dopaminergic Neurons of Transgenic Mice

(2011) Tatyana A. Shelkovnikova et al.   Neurodegenerative Diseases

Astrocyte–neuron metabolic relationships: for better and for worse

(2011) Igor Allaman et al.   TRENDS IN NEUROSCIENCES

A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease

(2010) Karl Kieburtz   ARCHIVES OF NEUROLOGY

Mechanisms Underlying Inflammation in Neurodegeneration

(2010) Christopher K. Glass et al.   CELL

Discovery of a Proneurogenic, Neuroprotective Chemical

(2010) Andrew A. Pieper et al.   CELL

From Anti-allergic to Anti-Alzheimer ’ s: Molecular Pharmacology of Dimebon™

(2010) I. Okun et al.   Current Alzheimer Research

Intrinsic disorder in proteins associated with neurodegenerative diseases

(2010) Vladimir et al.   Frontiers in Bioscience-Landmark

Cognition-Enhancing Properties of Dimebon in a Rat Novel Object Recognition Task Are Unlikely to Be Associated with Acetylcholinesterase Inhibition or N-Methyl-D-aspartate Receptor Antagonism

(2010) M. Giorgetti et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Dimebon Inhibits Calcium-Induced Swelling of Rat Brain Mitochondria But Does Not Alter Calcium Retention or Cytochrome C Release

(2010) Kranthi Kumari Naga et al.   NEUROMOLECULAR MEDICINE

Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions

(2010) Trevor Archer et al.   NEUROTOXICITY RESEARCH

Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models

(2009) Makiko Yamashita et al.   FEBS LETTERS

γ-Synucleinopathy: neurodegeneration associated with overexpression of the mouse protein

(2009) Natalia Ninkina et al.   HUMAN MOLECULAR GENETICS

Liquid chromatography–tandem mass spectrometry method for the quantification of dimebon in rat plasma and brain tissue

(2009) Ramakrishna Nirogi et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Acute dosing of latrepirdine (Dimebon™), a possible Alzheimer therapeutic, elevates extracellular amyloid-β levels in vitro and in vivo

(2009) John W Steele et al.   Molecular Neurodegeneration

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

(2008) Rachelle S Doody et al.   LANCET

Evaluation of Dimebon in cellular model of Huntington's disease

(2008) Jun Wu et al.   Molecular Neurodegeneration